Evidence map›Paper›PMID 39134531›Full record

ArticleCell discovery2024

Prediction of overall survival in stage II and III colon cancer through machine learning of rapidly-acquired proteomics.

Kailun Xu, Xiaoyang Yin, Hui Chen, Yuhui Huang, Xi Zheng, Biting Zhou, Xue Cai, Huanhuan Gao, Miaomiao Tian, Sijun Hu and 5 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Entering the Era of Multidimensional Prognostication for Personalized Risk Assessment in Stage III Colon Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kailun Xu *Department of Breast Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang, China), Cancer Institute, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.ORCID http://orcid.org/0000-0002-8458-3551
Xiaoyang Yin *Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Hui Chen *School of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.ORCID http://orcid.org/0000-0003-2866-7811
Yuhui HuangSchool of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Xi ZhengZhejiang Provincial Clinical Research Center for Cancer, Hangzhou, Zhejiang, China.
Biting ZhouZhejiang Provincial Clinical Research Center for Cancer, Hangzhou, Zhejiang, China.
Xue CaiSchool of Medicine, Westlake University, Hangzhou, Zhejiang, China.
Huanhuan GaoSchool of Medicine, Westlake University, Hangzhou, Zhejiang, China.
Miaomiao TianState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, Shaanxi, China.
Sijun HuState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, Shaanxi, China.
Shu ZhengZhejiang Provincial Clinical Research Center for Cancer, Hangzhou, Zhejiang, China.ORCID http://orcid.org/0000-0002-2521-190X
Changzheng YuanSchool of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. chy478@zju.edu.cn.
Yongzhan NieState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, Shaanxi, China. nieyongzhan@qq.com.
Tiannan GuoSchool of Medicine, Westlake University, Hangzhou, Zhejiang, China. guotiannan@westlake.edu.cn.ORCID http://orcid.org/0000-0003-3869-7651
Yingkuan ShaoDepartment of Breast Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang, China), Cancer Institute, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. ykshao@zju.edu.cn.ORCID http://orcid.org/0000-0001-9683-5691

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82203705
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39134531
PMCPMC11319451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.